Changes in endogenous cannabinoid homeostasis are associated with both ethanol-related neuroinflammation and memory decline. Extensive research is still required to unveil the role of endocannabinoid signaling activation on hippocampal microglial cells after ethanol exposure. Either microglial morphology, phenotype and recruitment may become notably altered after chronic alcohol-related neurodegeneration. Here, we evaluated the pharmacological effects of fatty-acid amide-hydrolase (FAAH) inhibitor URB597 (0.3 mg/kg), oleoylethanolamide (OEA, 10 mg/kg), arachidonoylethanolamide (AEA, 10 mg/kg), the CB1 receptor agonist ACEA (3 mg/ kg) and the CB2 receptor agonist JWH133 (0.2 mg/kg) administered for 5 days in a rat model of subchronic (2 weeks) ethanol diet (11% v/v) exposure. URB597 turned to be the most effective treatment. URB597 increased microglial (IBA-1+) cell population, and changed morphometric features (cell area and perimeter, roughness, fractal dimension, lacunarity) associated with activated microglia in the hippocampus of ethanol-exposed rats. Regarding innate immune activity, URB597 specifically increased mRNA levels of toll-like receptor 4 (TLR4), glial fibrillary acidic protein (Gfap) and the chemokine stromal cell-derived factor 1 (SDF-1α/CXCL12), and elevated the cell population expressing the chemokine receptors CX3CR1, CCR2 and CCR4 in the ethanol-exposed rat hippocampus. Contrary to ethanol effect, URB597 reduced mRNA levels of Iba-1, Tnfα, IL-6 and the monocyte chemoattractant protein-1 (MCP-1/CCL2), as well as cell population expressing iNOS. URB597 effects on hippocampal immune system were accompanied by changes in short and long-term visual recognition memory. These results suggest that FAAH inhibition may modulates hippocampal microglial recruitment and activation that can be associated with improved hippocampal-dependent memory despite ethanol exposure.
Introduction
Excessive alcohol consumption may increase the risk of alcohol-induced cognitive impairment, especially among teenagers, given that heavy binge-drinking is becoming the most frequent pattern of use in young people [25, 32] . If the consumption is prolonged, several damage might appear, eventually leading to encephalitis and dementia. Substantial scientific evidence in human and experimental animals has demonstrated this vulnerability of the central nervous system to chronic ethanol exposure which starts with changes in brain structure and functions such as synaptic plasticity and neural connectivity [45] . Morphometric anomalies, such as smaller volume of the prefrontal cortex, hippocampus and cerebellum [15, 16] , were associated with axonal atrophy, cellular membrane breakdown and myelin loss in the brain of heavy-drinking adolescents and adult alcoholics [27, 49] . The above structural changes in limbic system, such as the hippocampus that participate in learning and memory processes, have been correlated with cognitive dysfunctions and neurophysiological abnormalities in heavy drinkers such as poorer verbal declarative memory and alterations in attentional and visual working memories [34, 44] , affecting https://doi.org/10.1016/j.bcp.2018.08.005 Received 4 June 2018; Accepted 6 August 2018 later social anxiety and drug self-administration [69, 62] . Neuropathological consequences induced by alcohol drinking along late stages of development (i.e. adolescence) concomitantly occur with modifications in the innate immune system, which markedly influence the refinement of dynamic processes during maturation stages that finally impact on the adult brain functions [37] .
New insights suggest alterations in the neuroimmune signaling in alcohol-induced brain injury and long-lasting cognitive and memory consequences [11, 12] . Neuroimmune cells, such as microglia and astrocytes, are important players for neurocircuitry refinement and selective removal of unwanted synapses (pruning) during adolescence [59, 9] , as well as maintenance of normal myelinogenesis in adulthood [26] . Alcohol intake activates innate immune response through toll-like receptor 4 (TLR4) in microglial cells, astrocytes and macrophages by increasing the production of pro-inflammatory factors such as cytokines (TNFα, IL-1β), chemokines (MCP-1, MIP-1α, eotaxin-1), reactive nitrogen and oxygen species [7, 22, 45] . In this sense, HMGB1-TLR4 tolerance or sensitization and NF-κB target genes in monocytes and macrophages becomes a pivotal role in ethanol-induced inflammatory cytokine production and cognitive dysfunctions that depends on acute or repeated ethanol exposure [38, 3] , for instance, becoming less or more responsive to lipopolysaccharide stimulation [2, 67] .
Recent evidences indicate the importance of the endogenous cannabinoid and N-acylethanolamine (NAE)-based signaling system (ECS) in many actions of alcohol on the brain such as addiction, behavior, inflammation and neurogenesis [60, 54, 5, 24, 58] . Considering this issue, a great deal of emphasis has been placed on evaluating the effects of compounds targeting ECS (e.g. drugs modulating endocannabinoid tone) on the adaptive and innate branches of the immune system [57, 3, 22] . Endocannabinoids (eCBs) are lipid-derived molecules that targeting to G protein-coupled cannabinoid type-1 and type-2 receptors (CB1 and CB2) may preserve glial cell subpopulations against numerous insults that disturb cell homeostasis and integrity including excitotoxicity, mitochondrial dysfunction, proteostasis and oxidative stress [22] . While how CB1 receptors regulate microglia functions remains controversial, CB2 receptor up-regulation in conditions where neuroinflammatory changes (e.g. Alzheimer's disease, multiple sclerosis) occurs as part of a microglia activation process [63] .
It is known that microglial function and morphology are closely related [20] , but no studies have addressed whether neuroinflammation induced by alcohol might modify microglial phenotype (i.e. morphology, neuroimmunochemical phenotype) through an eCB-dependent mechanism. Since this alcohol-induced microglial modification might also affect memory and cognition, this is a relevant issue when thinking on potential therapeutics utilities of ECS-related drugs. Here, we investigated this potential therapeutic utility by analyzing the pharmacological effects of the repeated administration (5 days) of the NAEs hydrolyzing enzyme FAAH inhibitor URB597 (0.3 mg/kg), compared to OEA (10 mg/kg), AEA (10 mg/kg), ACEA (3 mg/kg) and JWH133 (0.2 mg/kg), in a rat model of subchronic (2 weeks) voluntary oral ethanol exposure. Microglia phenotyping (IBA-1, iNOS), morphometric parameters (fractal dimension, lacunarity, roughness, cell area, cell perimeter, density, among others), glial recruitment (chemokine receptors CX3CR1, CCR2, CCR4, CXCR4) and mRNA levels of cytokines related to innate immune TLR4 signaling (TNFα, IL-1β, IL-6) and chemotactic cytokines (fractalkine/CX3CL1, MCP-1/CCL2, SDF-1α/ CXCL12, eotaxin-1/CCL11) were analyzed in the hippocampus of ethanol-exposed rats. Regarding behavior associated with hippocampal functioning, short and long-term visual recognition memory was also assessed.
Materials and methods

Ethics statement
The protocols for animal care and use were approved by the Ethics 
Animals
Male Wistar rats (approximately 250 g, 10-12 weeks old; Charles Rivers, Barcelona, Spain) were housed individually in cages maintained in standard conditions (Centro de Experimentación Animal, Universidad de Málaga) at 20 ± 2°C room temperature, 40 ± 5% relative humidity and a 12-h light/dark cycle with dawn/dusk effect. Water and standard rodent chow (Prolab RMH 2500, 2.9 kcal/g) were available ad libitum, unless otherwise indicated for specific experimental procedures.
Habituation to alcohol-supplemented diet
Seventy-two animals were daily weighed, handled for 10 min and habituated to injection procedures (holding and pseudo-injection) during one week before the experimentation in order to minimize stress effects. To habituate the animals to feeding procedures, rats were first food-deprived to 95% of their free-feeding weight and then they were allowed ad libitum access to a complete and balanced chocolate-flavored liquid food (0.97 kcal/mL; Glucerna SR, Abbott Laboratories, Madrid, Spain) until a stable rate of feeding was reached (∼50 mL/day, up to 2-3 days). Then, the rats were divided into two groups (n = 36) and fed with the chocolate-flavored liquid diet supplemented with 11% (v/v) ethanol 96°(alcohol liquid diet) or 14.7% (w/v) sucrose (sucrose liquid diet) [60] . Both alcohol and sucrose liquid diets were formulated to contain the same calories (1.4 kcal/mL). Thus, the same volume of ethanol liquid diet consumed ad libitum was given the next day to the rats fed with the sucrose liquid diet. The rats were maintained under a controlled-isocaloric pair feeding period until a stable rate of alcoholic feeding was reached (∼30 mL/day, up to one week). In any case, standard rodent chow was not given, but water was available ad libitum, during the experimentation (see [54] for further details).
Drug administration
After alcohol diet habituation, rats were fed ad libitum with both liquid diets (ethanol or sucrose) and treated with the FAAH inhibitor URB597 (cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester; cat. no. 10046, Cayman Chemical, Ann Arbor, MI, USA), the endogenous PPARα and GPR55 receptor agonist OEA (oleoylethanolamide; cat. no. 1484, Tocris, Abingdon, UK), the endogenous cannabinoid and TRPV1 receptor agonist AEA (arachidonoylethanolamide; cat. no. 1339, Tocris), the potent and highly selective CB1 receptor agonist ACEA (arachidonyl-2′-chloroethylamide; cat. no. 1319, Tocris), and the potent and selective CB2 receptor agonist JWH133 (cat. no. 1343, Tocris). Drugs were dissolved in a vehicle containing 33% (v/v) DMSO in sterile 0.9% NaCl solution, just before each experiment, and were intraperitoneally (i.p.) injected in a final volume of 1 mL/kg of body weight. The optimal dose at which treatment would be more effective in neuroprotection was selected as described previously (Rivera et al., 2015a,b) . Thus, URB597, OEA, AEA, ACEA and JWH133 were repeatedly administrated at respective doses of 0.3, 10, 10, 3 and 0.2 mg/ kg body weight for 5 consecutive days at intervals of 24 h (08:00 a.m.). The animals were sacrificed 2 h after the last injection of the drugs. Finally, we obtained twelve experimental groups depending on the diet and treatment.
Object recognition test
The object recognition (OR) test was conducted to assess recognition memory during the week of treatment [19] . All testing was conducted in a 38 x 40 cm opaque plastic rectangular arena with 54 cm high walls. One day before testing, animals received a session in the experimental room for acclimatization. During the test, rats were individually set into the arena where two identical objects were placed. Animals were allowed to explore the apparatus and the objects for 10 min (sample trial). Two hours (short-term) and twenty-four (longterm) hours later, the rats were then returned twice more to the arena and were presented with one familiar object and one novel object. The animals were allowed to explore the apparatus and objects for 10 min (retention trial; [48] . The apparatus was evenly illuminated at approximately 70 lux and the device and the objects were thoroughly clean between trials. All possible location or object combinations were employed to prevent bias due to a preference for a particular object or specific location by using a counterbalanced procedure within treatment groups. Animals were considered to be exploring an object when their snout was directed towards it at a distance of 2 cm or less. The time spent (duration), distance and frequency exploring the objects by rats were scored using a video monitor. Discrimination index (d1) was calculated using the following formula: d1 = N/(N + F), where N is the amount of time that rats expend exploring the novel object and F is the amount of time that rats explore the familiar object. The same formula was applied for distance (space surrounding the object) and frequency (times of snout touching on object) of exploration.
Sample collection
Previous to sacrifice, all animals were i.p. anaesthetized (sodium pentobarbital, 50 mg/kg body weight) in a room separate from the other experimental animals. The animals were sacrificed by decapitation and their brains were collected, quick frozen and stored at −80°C. These brains were then disected on dry ice to obtain sections of 1 mm thick by using razor blades and a rat brain slicer matrix. The dorsal hippocampus was precisely removed from −2.16 to −4.20 mm of Bregma levels [47] with fine surgical instruments. Hippocampal samples were weighed and stored at −80°C until they were used for real time quantitative polymerase chain reaction (RT-qPCR) analysis. A replicated batch of rats were transcardially perfused with 4% formaldehyde in 0.1 M phosphate buffer (PB), and the brains were dissected and kept in the same fixative solution overnight at 4°C. The brains were cryoprotected and cut into 30-µm-thick coronal sections using a sliding microtome (Leica VT1000S). Sections were divided in eight parallel series until use for immunostaining.
RNA isolation and RT-qPCR analysis
We performed RT-qPCR (TaqMan, Applied Biosystem, Carlbad, CA, USA) as described previously [53] using specific sets of primer probes (see Table 1 ). Briefly, hippocampal samples were homogenized on ice and RNA was extracted following Trizol® method according to the manufacture's instruction (Gibco BRL Life Technologies, Baltimore, MD, USA). RNA samples were isolated with RNAeasy minelute cleanup-kit including digestion with DNase I column (Qiagen, Hilden, Germany). After reverse transcript reaction from 1 μg of mRNA, quantitative realtime reverse transcription polymerase chain reaction (qPCR) was performed in a CFX96TM Real-Time PCR Detection System (Bio-Rad, Hercules, CA, USA) and the FAM dye label format for the TaqMan® Gene Expression Assays (ThermoFisher). Melting curve analysis was performed to ensure that only a single product was amplified. Ct values were normalized in relation to Gapdh mRNA levels.
Immunohistochemistry
Free-floating coronal sections from −2.16 to −4.20 mm of Bregma levels were selected [53] . Sections were incubated overnight at 4°C in the following diluted primary antibodies: polyclonal rabbit anti-IBA-1 (1:1000, Wako, cat. no. 019-19741), monoclonal mouse anti-iNOS (10 µg/mL, R&D Systems, cat. no. MAB9502), monoclonal mouse anti-GFAP (1:500, Sigma-Aldrich, cat. no. G3893), polyclonal rabbit anti-CX3CR1 (1:500, Abcam, cat. no. ab8021), polyclonal rabbit anti-CCR2 (1:300, Novus Biologicals, cat. no. NBP1-78169), polyclonal rabbit anti-CCR4 (1:300, Novus Biologicals, cat. no. NB100-56336) and monoclonal rabbit anti-CXCR4 (1:300, Abcam, cat. no. ab124824). The following day the sections were washed and incubated in biotinylated donkey anti-rabbit IgG (1:500, GE Healthcare, cat. no. RPN1004) at room temperature for 1.5 h. Then, sections were incubated in ExtrAvidin peroxidase (Sigma-Aldrich) diluted 1:2000 in darkness at room temperature for 1 h. Finally, immunolabeling was revealed with 0.05% diaminobenzidine (DAB, Sigma-Aldrich), 0.05% nickel ammonium sulfate (Ni) and 0.03% H 2 O 2 in PB-saline for 10 min.
Stereological cell quantification
The average density of immunoreactive cells per animal was manually quantified using stereological methods. Estimations of the number of cells per sections (30 µm deep) and area (mm 2 ) in both hemispheres were calculated according to the following formula: N a = Σ(Q−)/Σ(a str ), where ΣQ− is the total number of positive (+) cells counted per animal, and a str is the area of the structure analyzed. Each structure analyzed consisted of approximately 8 coronal sections (from −2.16 to −4.20 mm Bregma levels), which resulted in one of every eight equidistant sections (one representative section for each 240 µm) according to the rostro-caudal extent. IBA-1+, iNOS+, GFAP +, CX3CR1+, CCR2+, CCR4+ and CXCR4+ cell counts were performed in the dentate gyrus (DG) and CA3 and CA1 hippocampal areas. Representative counting frames were evaluated using a standard optical microscope with the 40x objective (Nikon Instruments Europe B.V., Amstelveen, The Netherlands) coupled to the NIS-Elements Imaging Software 3.00 (Nikon). Quantification was expressed as the average number of positive cells per area (mm 2 ) for each experimental group. Glial fibrillary acidic protein; Iba1, ionized calcium-binding adapter molecule 1; IL-1β, interleukin 1 beta; IL-6, interleukin 6; Tnfα, tumor necrosis factor alpha; TLR4, toll-like receptor 4; eotaxin-1/CCL11, eosinophil chemotactic protein (C-C motif chemokine 11); fractalkine/CX3CL1, chemokine (C-X3-C motif) ligand 1; MCP-1/CCL2, monocyte chemoattractant protein 1 (chemokine (C-C motif) ligand 2); SDF-1α/CXCL12, stromal cell-derived factor 1 (C-X-C motif chemokine 12).
Morphometric analysis
For image acquisition, digital color images of DG sections immunolabeled with IBA-1 antibody and DAB-Ni were obtained using an Olympus VS120 microscope. The UPLSAPO 60xO oil immersion objective was used to capture high resolution images (pixel size = 115 mm 2 ) of the selected areas. A multi-plane virtual-Z mode allowed to capture 20 images (1 µm thick) in 20 µm depth of the section, which were later combined to obtain a single high quality image including detailed magnification of ramified processes of the cells. Each scanned image was a TIFF file of 96 ppi, and contained at least 30 cells. For image processing, individual microglial cells were selected and cropped from the captured images according to the following criteria: (i) random selection throughout the molecular layer of the DG; (ii) no overlapping with neighboring cells, and (iii) complete nucleus and branches (at least apparently). Selection was done blinded to diet or treatment. Approximately 50 cells selected from 6 animals were analyzed for each experimental condition. Each single cell image was processed in a systematic way using FIJI free software (freely downloadable from https://imagej.net/Fiji) to finally obtain a "filled image" and its counterpart "outlined shape" as previously described [20] .
These filled and outlined cell images were subsequently used for morphometric analysis. Morphological features of microglial cells were quantified with the free software FracLac for ImageJ (Karperien, A., FracLac for ImageJ; available at the ImageJ website, NIH). The following 15 parameters were measured as previously described by , maximum mass center radius, diameter of the bounding circle (µm), maximum span across the convex hull (µm), the ratio maximum/minimum convex hull radii and the mean radius (µm).
Statistical analysis
Comparisons of data were carried out using SPSS Statistics software and GraphPad Prism version 5.04 software (GraphPad Software, San Diego, CA, USA). Data are expressed as mean ± SEM for at least six determinations per experimental group (see figure legends in each case). The Kolmogorov-Smirnov normality test, along with the Levene homoscedasticity test, were used to verify Gaussian distribution. Statistical analyses were performed using a two-way analysis of variance (ANOVA) with two factors being diet (sucrose and ethanol) and treatment (vehicle, URB597, OEA, AEA, ACEA and/or JWH133). The Kruskal-Wallis test was performed for the non-parametric data. In the pairwise comparison Tuckey's test was used when possible. A p-value less than 0.05 was considered statistically significant.
Results
URB5097 improves short and long-term memory in ethanol-exposed rats
We evaluated whether changes in microglial population, morphology and phenotyping related to innate immune system in the hippocampus of ethanol-exposed rats are associated with hippocampal behavioral functioning such as recognition memory. To this aim, we used a discrimination index [N/(N + F)] in parameters (distance, duration, frequency, duration/frequency) obtained from short-term and long-term object recognition (OR) tests. We found an ethanol effect on frequency in short-term OR test ( Rats exposed to ethanol showed an increased frequency in shortterm OR test and an increased duration in long-term OR test compared to sucrose ones (***p < 0.001; Fig. 1A,B) . Ethanol specifically reduced duration/frequency ratio in short-term, but not long-term, OR test (*p < 0.05; Fig. 1A,B) . URB597 increased duration/frequency ratio in both short-term and long-term OR tests in ethanol-exposed rats compared to vehicle ones ( # p < 0.05; Fig. 1A,B) . Additionally, distance and duration in short-term OR test as well as duration and duration/ frequency ratio in long-term OR test were elevated in URB597-treated ethanol-exposed rats compared to URB597-treated sucrose-exposed rats (*/***p < 0.05/0.001). In contrast, distance in long-term OR test was decreased in the same animals (*p < 0.05; Fig. 9B ). Tukey's test: */***P < 0.05/0.001 vs. sucrose-vehicle group; # P < 0.05 vs. ethanol-vehicle group.
URB597 induces morphometric changes in IBA-1-microglia of dentate gyrus
After image acquisition ( Fig. 2A) and processing (Fig. 2B) , we also analyzed the effects of OEA, JWH133, ACEA, AEA and URB597 on morphologic parameters of microglial cells expressing IBA-1 in the dentate gyrus (DG) of ethanol-exposed rats compared to those of sucrose-exposed ones (Fig. 2C) . We observed treatment effects on main morphometric parameters such as cell area (CA), cell perimeter (CP), density, roughness, fractal dimension and lacunarity (F 5,605 > 10.58, p < 0.0001), as well as the related parameters CHA, CHP, maximum span across the convex hull, diameter of the bounding circle, and the ratio maximum/minimum convex hull radii (F 5,605 > 2.28, p < 0.044). Prominent effects of ethanol on CP, CHA, CHP, density, roughness, fractal dimension, maximum span across the convex hull, convex hull span ratio, diameter of the bounding circle, the maximum mass center radius and the mean radius (F 1,605 > 12.33, p < 0.0005), as well as CA and lacunarity (F 1,605 > 4.51, p < 0.034), were also found. Interaction between factors was observed in CA, CHA, CP, roughness, fractal dimension, maximum span across the convex hull and diameter of the bounding circle (F 5,605 > 2.23, p < 0.049), suggesting that treatment effect on microglial morphology is ethanol dependent.
Ethanol specifically increased roughness of DG microglial cells in vehicle-treated rats compared to that of sucrose-vehicle ones ( ### p < 0.001; Fig. 3D ). URB597, but not the remaining drugs, increased CA, CP, density, roughness and fractal dimension of microglial cells in DG of both sucrose and ethanol-exposed rat groups (***p < 0.001; Fig. 3A-E) . AEA also increased CA and density of microglial cells in DG of ethanol-exposed rats (***p < 0.001; Fig. 3A,C) . In contrast, both AEA and URB597 specifically reduced lacunarity in microglial cells in DG of ethanol-exposed rats (*p < 0.05; Fig. 3F ). CA was increased in ethanol-exposed rats treated with AEA, as well as CP and roughness in ethanol-exposed rats treated with JWH133 and AEA, when they were compared to those of sucrose-exposed rats treated with the respective JWH133 and AEA ( ### p < 0.001; Fig. 3A, B, D) . In contrast, fractal dimension was reduced in ethanol-exposed rats treated with ACEA and URB597 compared to that of sucrose-exposed rats with the same treatments ( ### p < 0.001; Fig. 3E ). No significant changes in the remaining morphometric parameters were induced by OEA, JWH133, ACEA, AEA and URB597 in sucrose and ethanol-exposed rats (Fig. 4). 3.3. URB597 and AEA increased the number of IBA-1-microglia in the hippocampus Rats exposed to ethanol (10%) for 2 weeks were treated with OEA (10 mg/kg), JWH133 (0.2 mg/kg), ACEA (3 mg/kg), AEA (10 mg/kg) and URB597 (0.3 mg/kg) for 5 days. Two-way ANOVA (ethanol and treatment as factors) indicated treatment effects on the number of cells expressing IBA-1 in the DG, CA3, CA1 and the whole hippocampus (F 5,104 > 27.3, p < 0.0001). An ethanol effect on the number of IBA-1+ cell was only observed in CA3 hippocampal area (F 1,104 = 9.77, p = 0.0023), but not in the remaining hippocampal regions analyzed. Interaction between factors was found in the CA3 and CA1 hippocampal areas and the whole hippocampus (F 5,104 > 2.71, p < 0.023), suggesting that treatment effect on IBA-1+ cell population is ethanol dependent.
AEA and URB597 increased the number of IBA-1+ cells in the whole hippocampus, including DG, and CA3 and CA1 hippocampal areas, of sucrose-exposed rats, excepting CA3 of AEA-treated rats (*/**/***p < 0.05/0.01/0.001), and ethanol-exposed rats ( ### p < 0.001) compared to that of the respective sucrose and ethanol-vehicle rats (Fig. 5A-D) . In ethanol-exposed rats, OEA and JWH133 specifically increased the IBA-1+ cell population in CA3 area and whole hippocampus ( # p < 0.05; Fig. 5C, D) , as well as JWH133 in the DG ( # p < 0.05; Fig. 5A ), compared to ethanol-vehicle rats. In contrast, OEA and JWH133 specifically decreased the IBA-1+ cell population in CA3 area of sucrose-exposed rats compared to sucrose-vehicle rats (*p < 0.05; Fig. 5B ). Representative images of hippocampus are shown in Fig. 5E .
URB597 decreased the microglial iNOS+ cell subpopulation in the hippocampus
We also evaluated the effects of OEA, JWH133, ACEA, AEA and Fig. 2 . Pre-processing of cell digital image. After random selection of DG microglial cells from each experimental condition (A), the images were filtered, changed to grayscale and transformed into a binary image. We finally obtained a filled shape and its pairwise outline shape (B) to be used for morphological parameters measures (C).
URB597 on the number of resident innate immune cells expressing iNOS (a cytokine-inducible immune defense) and GFAP (astroglia) in the hippocampus of ethanol-exposed rats. We observed treatment effects on the number of iNOS+ cells in the DG, CA3, CA1 and the whole hippocampus (F 5,104 > 5.69, p < 0.0002). An ethanol effect on the number of iNOS+ cell was only observed in DG and CA1 (F 1,104 > 4.93, p < 0.028), but not in CA3 and the whole hippocampus. Interaction between factors was found in the DG, CA3, CA1 and the whole hippocampus (F 5,104 > 4.44, p < 0.001), suggesting that treatment effect on iNOS+ cell population is ethanol dependent.
Ethanol reduced the number of cells expressing iNOS in the DG, CA3, CA1 and the whole hippocampus compared to that of sucrosevehicle ones (*/**p < 0.05/0.01; Fig. 6A-D) . All treatments (OEA, JWH133, ACEA, AEA and URB597) reduced the number of iNOS+ cells in the DG of sucrose-exposed rats compared to that of sucrose-vehicle rats (*/***p < 0.05/0.001; Fig. 6A ). AEA and URB597 also decrease the number of iNOS+ cells in CA3, CA1 and the whole hippocampus in the same rats (*/**/***p < 0.05/0.01/0.001; Fig. 6B-D) . Moreover, OEA also reduced the iNOS+ cell population in CA3 area and the whole hippocampus in sucrose-exposed rats (***p < 0.001; Fig. 6B, D) . However, the number of iNOS+ cells in JWH133-treated, sucrose-exposed rats was also lower in CA3 but higher in CA1 compared to those of sucrose-vehicle rats (*/**p < 0.05/0.01; Fig. 6B,C) . Regarding ethanol-exposed rats, URB597 specifically reduced the iNOS+ cell 
URB597 decreased the number of astroglial GFAP+ cells in the hippocampus
Treatment effects on the number of GFAP+ cells (astrocytes) were found in the DG, CA3, CA1 and the whole hippocampus (F 5,104 > 43.87, p < 0.0001). Ethanol effect and interaction were not observed.
While URB597 reduced the number of cells expressing GFAP in the DG, CA3, CA1 and the whole hippocampus of both sucrose and ethanolexposed rat groups, AEA increased it in all hippocampal regions of both rat groups compared to the respective vehicle rats (*/**/***p < 0.05/ 0.01/0.001, ### p < 0.001; Fig. 7A-D . In sucrose-exposed rats, OEA, JWH and ACEA also increased GFAP+ cell population in the DG and the whole hippocampus (*/***p < 0.05/0.001; Fig. 7A, D) . In ethanolexposed rats, JWH133 and ACEA increased the number of GFAP+ cells in the DG, and only JWH133 in the whole hippocampus, compared to vehicle ones ( ##/### p < 0.01/0.001; Fig. 7A, D) . Representative images of hippocampus are shown in Fig. 7E .
URB597 modulates hippocampal gene expression of cytokines and chemokines related to innate immune TLR4 system
We evaluated innate immune system related to TLR4 that regulates the gene expression of cytokines (Iba-1, Tnfα, IL-1β, IL-6) and chemokines (SDF-1α, MCP-1, eotaxin-1, fractalkine). Treatment effects on mRNA levels of TLR4 ( Specifically, mRNA levels of Iba-1, Tnfα, IL-6 and MCP-1 were increased in the hippocampus of ethanol-exposed rats compared to those of sucrose-exposed rats (*/***p < 0.05/0.001; Fig. 8A, B) . In the Fig. 4 . Effects of OEA, JWH133, ACEA, AEA and URB597 i.p. administrations during the last 5 days of ethanol exposure (10%) for 2 weeks on additional morphometric parameter such as convex hull area (A), convex hull perimeter (B), maximum span across the convex hull (C), convex hull span ratio (D), diameter of the bounding circle (E), cell circularity (F), the maximum mass center radius (G), the ratio maximum/minimum convex hull radii (H), and the mean radius (I) in microglial cells of the DG. The histograms represent the mean + SEM (n = 50 cells per experimental group).
hippocampus of ethanol-exposed rats, URB597 decreased mRNA levels of Iba-1, Tnfα, IL-6 and MCP-1, and increased mRNA levels of TLR4, Gfap and SDF-1α compared to those of vehicle-treated rats ( #/##/### p < 0.05/0.01/0.001; Fig. 8A, B) . Tnfα gene expression was also decreased in sucrose-exposed rats treated with URB597 compared to vehicle ones (***p < 0.001; Fig. 8A ).
URB597 increases the number of microglial cells expressing the chemokine receptors CX3CR1, CCR2 and CCR4
We found treatment effects on the number of cells expressing CX3CR1, CCR2 and CCR4 in the whole hippocampus ( The number of CX3CR1+ cells were reduced in the DG, CA3 and the whole hippocampus of ethanol-exposed rats compared to those of sucrose ones (**/***p < 0.01/0.001; Fig. 9A ). In contrast, the number of CCR4+ cells were specifically increased in CA3 of the same ethanolexposed animals (**p < 0.01; Fig. 9C ). In sucrose-exposed rats, URB597 increased the CX3CR1+ cells population in CA1, the CCR2+ cells population in the DG, CA3, CA1 and the whole hippocampus (Fig. 9A) , and the CCR4+ cell population in CA1 (Fig. 9B ) and the whole hippocampus (Fig. 9C) compared to vehicle ones (*/**/***p < 0.05/0.01/0.001). In contrast, the number of CXCR4+ cells was specifically decreased in the DG of sucrose-exposed rats treated with URB597 (*p < 0.05; Fig. 9D ). In ethanol-exposed rats, URB597 increased the number of CX3CR1+ cells in the DG, CA3, CA1 and the whole hippocampus (Fig. 9A) , the number of CCR2+ cells in CA1 and the whole hippocampus (Fig. 9B) , and the number of CCR4+ cells in the DG, CA1 and the whole hippocampus (Fig. 9C ) of ethanolexposed rats compared to those of vehicle ones ( ##/### p < 0.01/ 0.001). Representative images of DG are shown in Fig. 9E-H. 
Discussion
In the present study, we show that the FAAH inhibitor URB597 induced the most consistent changes in morphology (fractal analysis), phenotyping related to innate immune TLR4 system (TLR4, TNFα, IL-6) and glial recruitment through chemokines (SDF-1α/CXCL12, MCP-1/ CCL2) and chemokine receptors (CX3CR1, CCR2 and CCR4) in hippocampal microglia of rats exposed to ethanol. These effects of FAAH inhibition were clearly different from those observed after the administration of other natural or synthetic cannabinoids with differential sensitivity for CB1 or CB2 receptors (AEA, ACEA, JWH133), and different from those induced by the non-cannabinoid N-acylethanolamide OEA binding to PPARα receptors. These effects on microglial activity are likely associated with an improvement of object recognition memory despite ethanol exposure. To our knowledge, this is the first study that evaluates the influence of cannabinoids and ethanol on microglial phenotyping, morphology and hippocampal-dependent memory.
Ethanol effects on neuroinflammatory signaling and microglial morphology
Seminal studies demonstrated that alcohol induced changes in glial activation and immune signaling, affecting brain structure and function [10] . Repeated ethanol drinking increases the expression of different components of neuroimmune system such as innate immune receptors (TLR3, TLR4) and the production of NF-κB-related pro-inflammatory molecules including cytokines (i.e. TNFα, IL-1β, IL-6), chemokines (MCP-1, eotaxin-1), and nitric oxide resulting in neuroinflammation and oxidative stress [64, 51, 3, 22, 22, 45] . In the present study we replicated part of those findings since mRNA levels of Iba-1 as well as the cytokines Tnfα and IL-6 were increased in the hippocampus of rats exposed to ethanol for 2 weeks. Previous studies have not observed changes in Tnfa, IL-6 and Tlr4 mRNA levels, but described increases in Iba-1 mRNA levels and decreases in Gfap mRNA levels in adolescent and adult rodent hippocampus exposed to several binge drinking episodes [35, 30, 58] . Moreover, recent studies [13, 50] suggest that long-term ethanol exposure (20% or 11 g/kg) for up to 12 months promotes cytokine production (IL-1β, IL-15, TNFα) and induces a partial activation and increased density of microglia (CD11b, IL-1β).
Microglia, brain immune cells which contain ramified and dynamically moving processes, constantly surveil the brain parenchyma to detect dysfunction [42] . Microglia-related neuroinflammatory mechanisms include traveling to the sites of injury, following chemoattractive signals (chemokines), where they can recruit or activate other cells affecting processes such as proliferation, apoptosis and phagocytosis that contribute to neural repair and reorganization [29] . Studies using animal models of alcoholism [30] ; Anton et al., 2017) and subjects diagnosed of alcohol use disorders [29] indicated increased concentrations of the chemoattractant protein MCP-1 in the brain including hippocampus. We observed that ethanol exposure for 2 weeks increased MCP-1/CCL2 mRNA levels, but not other chemokines such as SDF-1α/CXCL12, eotaxin-1/CCL11 and fractalkine/CX3CL1 in the hippocampus of our rat model. Additionally, ethanol reduced the number of cells expressing iNOS (a cytokine-inducible immune defense) and the number of cells expressing the chemokine receptor CX3CR1 (fractalkine receptor) in the hippocampus. No overall changes were found in hippocampal populations of glial cells expressing IBA-1 (microglia) and GFAP (astroglia), as well as in the number of hippocampal cells expressing CCR2 (MCP-1 receptor), CCR4 (CCL17/CCL22 receptor) and CXCR4 (SCD-1α receptor). Concerning the role of immune system in subjects with alcohol use disorders (AUD), alcohol consumption has been shown to affect the circulating cytokines and chemokines [14, 22] . A recent study in patients with AUD revealed a link of the eosinophil chemotactic protein eotaxin-1/CCL11 with psychiatric comorbidity in a clear sex-dependent manner [22] . These authors also described that rats exposed to repeated and acute ethanol (3 g/kg, gavage) had changes in circulating concentrations of SDF-1α/CXCL12, fractalkine/CX3CL1 and eotaxin-1/CCL11 [22] . It is well established that microglial function and form by a variety and complex morphologies (ramified/intermediate/activated) are inextricably linked (Karperien et al., 2013; [20] . When abnormality in the brain function is present, microglia result in a changed morphology to be active in an inflammatory response (Morrison et al., 2017) . Thus, the objective quantification of microglial morphology (fractal analysis) provides an essential tool to discriminate the resting, quiescent or activated (reactive) form of microglia [61, 17] . In the present study, ethanol effect on microglial morphology was consistent in most morphometric parameters analyzed, suggesting a decrease in density, fractal dimension and lacunarity (Fig. 10A) . These results indicate that the morphologically and functionally dynamic microglia, when they are exposed to ethanol, mostly remain in a low ramified form with decreasing complexity of branching patterns that implies homogeneity in shape. These features likely agree with morphological categories of deramifying and/or activated microglia [31, 20] .
URB597 effects on neuroinflammatory signaling and microglial morphology
The neuroprotective properties of compounds targeting the endocannabinoid system include a modulatory effect on innate immune system. Several studies have supported the ability of cannabinoid activation (e.g. delta-9-tetrahydrocannabinol) to decrease inflammation with recent evidence indicating that neuroimmune changes, including microglial activation, were more profound in mice lacking CB2 receptor [18, 43] . Selective CB2 receptor activation prevents deficits in microglial activation and cognitive impairment, including the undesired psychoactive effects of neuronal CB1 receptor stimulation [56] . URB597, which by decreasing N-acylethanolamine hydrolysis lead to increased endocannabinoid tone including AEA and OEA, was described to attenuate age-related microglial activation such as the microglial markers MHCII, CD11b, CD68 and CD40 associated with decreases in mRNA levels of the proinflammatory cytokines Tnfα and IL-1β [41] , and reduced the number of microglial cells expressing IBA-1 [53] in the hippocampus of naïve rats. Consistently, a number of in vivo and in vitro studies have demonstrated that endocannabinoids and/or cannabinoid-like synthetic molecules (e.g. WIN-55,212-2) with CB2 receptor activity reduced microglial activation in brain of animals which received neurotoxic stimuli such as amyloid-β, interferon-γ or lipopolysaccharide [18, 55, 52] . Strikingly, our study indicates that FAAH inhibition through URB597, a drug that increase bioavailability of endogenous cannabinoid receptor agonists, was very effective on the attenuation of ethanolinduced increase in mRNA levels of the proinflammatory cytokines and chemokines Iba-1, Tnfα, IL-6 and MCP-1. Decreased neuroinflammation induced by URB597 can be likely associated with decreases in the number of GFAP+ cells (astrocytes) and glial cells expressing the immune response marker iNOS. Astrocytes also function as resident immune cells in the brain and can induce an inflammatory response by producing pro-inflammatory molecules (cytokine and chemokines) in a region-specific manner [30] . For instance, MCP-1 is a chemokine highly expressed in astrocytes that is able to alter addiction to alcohol [6] . Specifically, ethanol administration (6 g/kg) via gavage for 10 days increased mRNA levels of MCP-1 in the hippocampus and resulted in increased GFAP immunostaining [30] .
In the hippocampus of ethanol-exposed rats, URB597 induced a specific increase in the mRNA levels of TLR4, an inflammatory signaling system that plays a fundamental role in pathogen recognition and activation of innate immunity. Recently, special emphasis is given to the actions of ethanol in the inflammatory TLR4/NF-κB signaling response in glial cells triggering cytokines and chemokines [46] . In this sense, OEA was described to prevent neuroimmune HMGB1/TLR4/NF-κB signaling in the rat frontal cortex induced by ethanol binge administration [3] . We can speculate that URB597-induced local increases in OEA concentrations might mediate part of the effects observed in these biomarkers of alcohol-induced neuroinflammation.
Among a variety of available drugs affecting cannabinoid activity and N-acylethanolamine tone (i.e. AEA, ACEA, JWH133, OEA, URB597), both AEA and URB597 increased the number of microglial cells expressing IBA-1 in the hippocampus under an alcoholic context, suggesting a role of cannabinoid receptors in microglial recruitment and activation following specific neurotoxic stimuli. These results agree with enhanced microglial density in the hippocampus of faah -/-mice [4] . In agreement with this observation, URB597 increased mRNA levels of the chemokine SDF-1α, but no changes were found in eotaxin-1 and fractalkine in the hippocampus of ethanol-exposed rats. Additionally, URB597 increased the hippocampal cell population expressing the chemokine receptors CX3CR1, CCR2 and CCR4. We hypothesized that increased microglial population in a lower activated state (morphology and iNOS) may be associated with chemoattraction/recruitment processes (increased SDF-1α and chemokines receptors) to induce an anti-inflammatory signaling (reduced Iba-1, Tnfα, and IL-6). Several studies indicated that accumulation of microglia is associated with increased mRNA expression of Cnr2 (CB2 receptor), CX3CR1 and CCR2 under specific neurodegenerative conditions, effects on microglia that were inhibited by cannabinoid activation [21] . However, under an alcoholic context, Cnr2 mRNA levels were specifically decreased in the rat hippocampus [58] , suggesting a different modulatory role of the endocannabinoid system in ethanol-related neuroinflammation. In this sense, special attention should be given to CX3CR1 role in neuroinflammation as rising hypothesis suggests that CB2 receptor activation (i.e. JWH133) accelerates CX3CR1+ microglia secreting neurotrophic factors and restores damaged neuronal circuit [68] . URB597 also promotes morphologic changes in microglia. Changes in relevant morphometric parameters suggest that URB597 likely modulate ethanol-related microglial activation by enhancing cell area, cell perimeter, roughness and lacunarity (less polarization), and reverting ethanol-induced decreased density and fractal dimension (higher complexity of branching/ramified processes) that could be relevant in response to ethanol (Fig. 10) . Regarding the literature, only a previous study described an effect of cannabinoid activation (cannabidiol and Δ 9 -THC) on amoeboid versus branched phenotypes of mouse microglial cell line BV-2 [36] . Further in vitro studies are needed to understand whether URB-mediated FAAH inhibition directly produces effects on microglial cells or it is derived from a complex interconnected signaling between astrocytes and neurons surrounding microglial cells in brain tissue. Indeed, this is a limitation of the present study that will be addressed in future experimental approaches.
URB597 effects on cognitive and memory function
The endocannabinoid system is a key regulator of memory consolidation for aversive experiences [39] . Considerable evidence demonstrates that cannabinoid agonists impairs whereas cannabinoid antagonists improve memory [1] . However, these simple patterns on learning is not always reliable when emotional memory processes are involved [23, 33] . In this regard, despite controversies [8] , URB597 was described to facilitate memory consolidation through a concurrent activation of both CB1 and CB2 receptors within prefrontal-limbic circuits [40, 28] . Moreover, accumulated evidence indicate an association between neuroinflammation and cognitive impairment, a relationship that can be likely mediated by the immunomodulatory effect of CB2 receptor controlling microglial activity [66] and neuroprotection by preventing neuronal apoptosis and improving cognition via PI3K/AKT signaling [65] . The current study assessed the association among cannabinoid activation, neuroinflammation and memory improvement despite ethanol exposure.
Conclusions
These findings indicate that increased N-acylethanolamine signaling (AEA, OEA) achieved through inhibition of its metabolizing enzyme FAAH by URB597 may modulate microglial morphology and phenotyping (cytokines and chemokines) via innate immune TLR4 signaling that may be effectively associated with ethanol-related neuroinflammatory activity and an improved hippocampal-dependent memory despite ethanol exposure.
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